The head of Philip Morris International has said the cannabis market remains too risky for it to follow rival cigarette maker Altria by making a significant investment in the nascent sector.

André Calantzopoulos, chief executive, stressed that there was a paucity of scientific data on the long-term impact of cannabis. Because international regulators were adopting different approaches to the drug, there could be logistical and reputational risks, he said.